Negotiated reimbursement rates for D5991 across 32 states, sourced from CMS Transparency in Coverage data. 204 rate records.
D5991 refers to the application of a medicament carrier specifically designed for patients with vesiculobullous diseases, such as pemphigus vulgaris or mucous membrane pemphigoid. This procedure is essential for delivering therapeutic agents directly to affected oral tissues, aiding in the management of painful lesions. Documentation should include a detailed clinical history, the specific condition being treated, and the rationale for using a medicament carrier. Reimbursement for this procedure can vary significantly by payor and state, with some insurance plans covering it under medical benefits rather than dental, leading to discrepancies in average reimbursement rates, which hover around $135.
Reimbursement rates for D5991 vary significantly by state, payor, and provider network. The national average negotiated rate is $135. Data sourced from CMS Transparency in Coverage machine-readable files, updated monthly.
29+ more states available with Pro ↓